For a cancerous tumor to grow, it must overpower immune cells known as T cells. TIL((tumor-infiltrating lymphocyte – or TIL therapy) is showing promise in advanced lung cancers through clinical trials underway. Therapy restores the immune system’s natural ability to fight cancer cells.
Giving immune system cancer-attacking power back
Lynch Syndrome Ireland 